Companies
Kuehne+Nagel
operates a "Cool Corridor" network of temperature-controlled logistics lanes for healthcare shipments, recently expanding both its air-logistics cool-chain coverage and its North American healthcare footprint.
- Country
- Switzerland
EU
Coverage
| CN | EU | US | |
|---|---|---|---|
| regulatory-legal | ✓ | ✓ | ✓ |
Regulatorsfda
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Revenue | CHF 24,476 million net turnover for 2025 | 2025-annual-report.kuehne-nagel.com · newsroom.kuehne-nagel.com |
| Headcount | 85,407 employees as of 2025-12-31 | 2025-annual-report.kuehne-nagel.com · newsroom.kuehne-nagel.com |
| Certification | HealthChain, IATA CEIV Pharma, GxP, and GMP certifications | aircargoweek.com · newsroom.kuehne-nagel.com · kuehne-nagel.com |
| Production site | Over 100 GxP-compliant, IATA CEIV-certified airfreight stations, plus specific temperature-controlled facilities in Hyderabad and Bengaluru as of 2026-05-05 | aircargoweek.com · newsroom.kuehne-nagel.com |
| Regulatory approval | Operations comply with GDP, GxP, and GMP standards | aircargoweek.com · cargoforwarder.eu · newsroom.kuehne-nagel.com · kuehne-nagel.com · stattimes.com |
Independent sources: aircargoweek.com · cargoforwarder.eu · stattimes.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Bio import/export customs brokerage | regulatory-legal | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.